● Latest
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA) Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment RIG 101 Trial in Healthy Adults and Adults With Asthma
Media Kit 2026

ClinicalIQ Media Kit

Everything you need to plan and book a campaign with ClinicalIQ — audience data, formats, rates, and specs.

Download PDF Kit ↓
About ClinicalIQ

The UK's evidence-first clinical information platform for HCPs

ClinicalIQ aggregates NICE guidelines, MHRA safety updates, NHS England pathways, SIGN guidance, and the latest clinical trial data into a single, searchable platform — built by a pharmaceutical medicine specialist for the clinical community.

Our mission: give every UK clinician instant access to the evidence they need at the point of care. Your partnership makes that possible — while giving your brand unmatched visibility with a verified, engaged HCP audience.

Founded by Dr Anzal Qurbain
MBBS BSc(Hons) MBA FFPM — Pharmaceutical Medicine Specialist & ABPI Code Expert
10,000+
Registered HCPs
(growing 15% MoM)
68%
GPs & Consultants
by specialty
42%
Avg Email Open Rate
2× industry avg
8 min
Avg Session Duration
high engagement
£0
Always Free
to HCPs
100%
ABPI Compliant
all sponsorships

Audience Breakdown

By Specialty
GP / Primary Care 34%
Hospital Consultant 26%
Registrar / SHO 18%
Pharmacist 10%
Nurse Prescriber 8%
Other HCP 4%
By Therapeutic Interest
Oncology 28%
Cardiovascular 22%
Respiratory 18%
Diabetes & Endocrinology 16%
Neurology 10%
Other 6%
Key Metrics
Monthly unique HCPs 10,000+
Page views / month 85,000+
Newsletter subscribers 7,500+
Newsletter open rate 42%
Newsletter click rate 12%
Avg session duration 8 min
Mobile traffic 54%
Returning visitors 67%

Sponsorship Formats & Rates

Format Description Reach Rate Compliance
Webinar Sponsorship CPD-accredited event, KOL-led 500–2,000 attendees £5,000–£30,000 Full ABPI review
Guideline Content Sponsorship Sponsored summary article on your TA 5,000–15,000 views £2,000–£8,000 Declared sponsorship
TA Hub Sponsorship Dedicated area for your therapeutic area Monthly active users £1,000–£5,000/mo Declared sponsorship
Newsletter Feature Sponsored slot in weekly digest 7,500 subscribers, 42% open £500–£2,000 Labelled "Sponsored"
Email Broadcast Standalone campaign to full list 7,500 HCPs £1,500–£3,000 Full ABPI review
Leaderboard (728×90) Header of every page 85,000 impressions/mo £25–£40 CPM Ad review included
MPU (300×250) Premium sidebar position 60,000 impressions/mo £20–£35 CPM Ad review included
Half Page (300×600) High-impact sidebar 40,000 impressions/mo £30–£45 CPM Ad review included
In-Content Banner Within guideline articles High intent context £15–£25 CPM Ad review included
PSP Listing — Free Patient support programme listing Condition-specific reach Free Compliance verified

Creative Specifications

Submit creative to [email protected] at least 5 business days before campaign start. All creative subject to ABPI compliance review.

Leaderboard
728 × 90px
JPG, PNG, GIF, HTML5
Max 150KB, 15fps max for GIF
MPU
300 × 250px
JPG, PNG, GIF, HTML5
Max 150KB
Half Page
300 × 600px
JPG, PNG, GIF, HTML5
Max 200KB
Mobile Banner
320 × 50px
JPG, PNG
Max 50KB
ABPI Compliance: All pharmaceutical advertising to HCPs must comply with the ABPI Code of Practice. ClinicalIQ will review all creative before publication. We reserve the right to decline any ad that does not meet compliance requirements. Third-party ABPI certification reference required for materials already pre-approved by your MLR team.

How to Book

1
Enquire
Complete the form below or email [email protected] with your brief and budget
2
Proposal
We respond within 24 hours with a tailored proposal and available dates
3
Compliance Review
We review all content/creative against the ABPI Code before approval
4
Go Live
Campaign launches, you receive regular performance reports throughout

Ready to Reach UK HCPs?

Email us with your brief and we'll put together a tailored proposal within 24 hours.

[email protected] View Sponsorship Packages

Join 10,000+ UK Clinicians

Get weekly clinical updates — guidelines, trials, MHRA alerts — delivered to your inbox. Free for verified HCPs.

By registering you confirm you are a healthcare professional. No spam. Unsubscribe anytime.